Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FP9CK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,276
Award facts
- Contract value 100% obligated
- $62,276.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 30, 2026, with an ultimate completion date of February 2, 2026, for the supply of Gemtesa 75 mg tablets (90-count units) at a ceiling value of $62,276.14. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location.
This delivery order is executed under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at up to $999,999,999.00 through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Gemtesa, a specialty pharmaceutical for overactive bladder treatment, represents one of multiple therapeutic domains covered under this strategic global pharmaceutical support vehicle serving the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FP9CK?
SPE2DR26FP9CK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FP9CK worth?
The government has obligated $62,276 on SPE2DR26FP9CK.
Is contract SPE2DR26FP9CK an order under another contract?
Yes. SPE2DR26FP9CK is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9CK competed?
The extent of competition for SPE2DR26FP9CK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award